Straberi Epistamp Device for Postinflammatory Hyperpigmentation

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 23, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

October 12, 2023

Conditions
Postinflammatory Hyperpigmentation
Interventions
DEVICE

Straberi Epistamp

The patient's entire face will be treated. The following settings will be used as a treatment protocol. Needle length between .02- 1.55 mm

Trial Locations (1)

10028

Lavish, New York

All Listed Sponsors
collaborator

Lavish Beauty

UNKNOWN

lead

Universal Skincare Institute

OTHER